Winton Gibbons is a consultant focused on market assessment, business development, strategy, and new product innovation. His client emphasis is in various life science fields, including diagnostics, life science research tools, medical devices, biotechnology, and pharmaceuticals.
His background is unique, since it merges experience as a top-tier consultant with McKinsey, as a partner with investment bank William Blair, and as an executive in industry as a VP with Roche Diagnostics, and SVP roles with various mid-sized diagnostic and life science firms.
Most recently, Winton completed four projects for a major diversified life science firm. These included assessment of adjacent service and product markets, support for divisional strategic planning, a 5-year analysis with synthesis of key initiatives, and detailed assessment of a potential corporate venture investment. Other recent engagements include an assessment of the physician office laboratory market for a top 3 medical device firm, and for a top 5 biopharma firm, development of a companion diagnostics assessment and deployment process. Winton has also acted as a subject matter expert for A large CDMO.
For early- and mid-stage in-vitro diagnostic and life science firms, Winton has conducted numerous engagements and executive counseling.
Since 2010, he has been on the Investor Advisory Board for the Innovation and New Ventures Office of Northwestern University, and since 2000, a member of the organizing committee for the AACC annual Financial Analyst Briefing.
|Corporate Development||Senior Vice President|
|Agena Bioscience (2015 – 2016)||Genetic Testing (Mass Spectrometry)|
|CEO & President|
|Siloam Biosciences (2014 – 2015)||Clinical Diagnostics (Microfluidics)|
|Business Development||Senior Vice President|
|Nanosphere (2007 – 2013) (acquired by Luminex)||Clinical Diagnostics (Nanotechnology)|
|Strategic Marketing & Product Management||Senior Vice President|
|Biosite (2005 – 2007) (acquired by Alere)||Clinical Diagnostics (Biotechnology)|
|Healthcare Equity Research||Analyst, Principal, and Group Head|
|William Blair & Company (1997 – 2005)|
|Strategy & Business Development||Vice President|
|Boehringer Mannheim (1994 – 1997) (acquired by Roche)||Diagnostics and Pharmaceuticals|
|Management Services (internal consulting)||Director|
|Merck & Co. (1993 – 1994)||Pharmaceuticals|
|Management Consulting||Engagement Manager and Consultant|
|McKinsey & Company (1989 – 1993)|
|University of Chicago Booth School of Business||MBA Finance|
|Duke University||BS Chemistry|
|Patent filings – five published applications, numerous other disclosures and filings.|
|One thousand financial reports and commentaries.|
|Quoted by Biocentury, Bloomberg and Bloomberg TV, Boston Herald, CBS Market Watch, Chicago Tribune, CNBC TV, Dow Jones, Forbes, In Vivo, Investor’s Business Daily, MSNBC TV, Nature, New York Times, PBS, Reuters, San Francisco Chronicle, SmartMoney.com, TheStreet.com, USA Today, Wall Street Journal, and Washington Post.|